CARGO Therapeutics, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
CARGO Therapeutics, Inc. - overview
Established
2021
Location
San Carlos, CA, US
Primary Industry
Biotechnology
About
Based in California, US, and founded in 2021, Cargo Therapeutics, Inc operates as a cancer treatment-based biotechnology firm that develops an adoptive cell therapy to benefit patients from potentially curative treatment options. The company was founded by Crystal Mackall, Robbie Majzner, Nancy Goodman, and Louai Labanieh. In February 2023, CARGO Therapeutics, Inc. raised USD 68.
83 million in series A funding led by RTW Investments, Third Rock Ventures, and Xontogeny, LLC. As of 2023, the company is led by its CEO Gina Chapman. The company offers a scientific platform that provides multi-specific and multi-functional CAR T programs. It engineers CAR T-cell therapy to overcome resistance to cancer treatment and address barriers to access so that more patients may benefit from potentially curative therapies.
The company plans to use February 2023, funding to advance CARGO’s autologous CD22 CAR T-cell therapy candidate, CRG-022, through a pivotal multicenter Phase 2 trial in patients with LBCL whose disease has relapsed or is refractory to CD19 CAR T-cell therapy.
Current Investors
T Rowe Price, Wellington Management, Third Rock Ventures
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy
Website
www.cargo-tx.com
Verticals
Manufacturing
Company Stage
Mature
Total Amount Raised
Subscriber access only
CARGO Therapeutics, Inc. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| IPO | Completed | CARGO Therapeutics, Inc. | - |
Displaying 1 - 1 of 1
CARGO Therapeutics, Inc. - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.